Ropes & Gray Advises Sands Capital in $100 Million Series D Financing for Cytovale
October 17, 2024
October 17, 2024
BOSTON, Massachusetts, Oct. 17 -- Ropes and Gray, a law firm, issued the following news:
Ropes & Gray represented Sands Capital in leading $100 million in Series D financing for Cytovale, a commercial-stage medical diagnostics company focused on advancing early detection technologies to diagnose fast-moving and immune-mediated diseases.
The funding was announced in an Oct. 10 press release.
Sands Capital is an active, long-term investor in leading innov . . .
Ropes & Gray represented Sands Capital in leading $100 million in Series D financing for Cytovale, a commercial-stage medical diagnostics company focused on advancing early detection technologies to diagnose fast-moving and immune-mediated diseases.
The funding was announced in an Oct. 10 press release.
Sands Capital is an active, long-term investor in leading innov . . .